1.Analysis of the clinical characteristics and misdiagnosis of area postrema syndrome manifesting as intractable nausea, vomiting, and hiccups in neuromyelitis optica spectrum disorders.
Shi Min ZHANG ; Feng QIU ; Xuan SUN ; Hui SUN ; Lei WU ; De Hui HUANG ; Wei Ping WU
Chinese Journal of Internal Medicine 2023;62(6):705-710
Objective: To investigate the misdiagnosis of area postrema syndrome (APS) manifesting as intractable nausea, vomiting and hiccups in neuromyelitis optic spectrum disease (NMOSD) and reduce the risk of misdiagnosis. Methods: We retrospectively analyzed data from NMOSD patients attending the Department of Neurology at the First Medical Center of PLA General Hospital between January 2019 and July 2021. SPSS25.0 was then used to analyze the manifestations, misdiagnosis, and mistreatment of APS. Results: A total of 207 patients with NMOSD were included, including 21 males and 186 females. The mean age of onset was 39±15 years (range: 5-72 years). The proportion of patients who were positive for serum aquaporin 4 antibody was 82.6% (171/207). In total, 35.7% (74/207) of the NMOSD patients experienced APS during the disease course; of these patients, 70.3% (52/74) had APS as the first symptom and 29.7% (22/74) had APS as a secondary symptom. The misdiagnosis rates for these conditions were 90.4% (47/52) and 50.0% (11/22), respectively. As the first symptom, 19.2% (10/52) of patients during APS presented only with intractable nausea, vomiting and hiccups; 80.8% (42/52) of patients experienced other neurological symptoms. The Departments of Gastroenterology and General Medicine were the departments that most frequently made the first diagnosis of APS, accounting for 54.1% and 17.6% of patients, respectively. The most common misdiagnoses related to diseases of the digestive system and the median duration of misdiagnosis was 37 days. Conclusions: APS is a common symptom of NMOSD and is associated with a high rate of misdiagnosis. Other concomitant symptoms often occur with APS. Gaining an increased awareness of this disease/syndrome, obtaining a detailed patient history, and performing physical examinations are essential if we are to reduce and avoid misdiagnosis.
Male
;
Female
;
Humans
;
Child, Preschool
;
Child
;
Adolescent
;
Young Adult
;
Adult
;
Middle Aged
;
Aged
;
Neuromyelitis Optica/diagnosis*
;
Area Postrema
;
Retrospective Studies
;
Hiccup/complications*
;
Vomiting/etiology*
;
Nausea/etiology*
;
Inflammation
;
Syndrome
;
Autoantibodies
;
Diagnostic Errors
;
Aquaporin 4
2.Pregnancy-associated neuromyelitis optical spectrum disorder combined with primary Sjögren's syndrome: A critical illness case report.
Jie WU ; Wen ZHANG ; Shu LIANG ; Yi Lu QIN ; Wen Qiang FAN
Journal of Peking University(Health Sciences) 2023;55(6):1118-1124
Central nervous system involvement in primary Sjögren's syndrome (pSS) is less common and usually presents as white matter lesions, neuromyelitis optica spectrum disorder (NMOSD), or transverse myelitis. NMOSD is an immune-mediated inflammatory demyelinating disease of the central nervous system with a high rate of relapse and significant disability. Studies have shown that patients with pSS combined with NMOSD have more severe symptoms and poorer prognosis. Here, we present a case of critical illness in pregnancy-associated NMOSD combined with Sjögren's syndrome. The patient was a 30-year-old pregnant woman with a history of Sjögren's syndrome who was diagnosed with NMOSD. She received combination therapy with steroids, intravenous immunoglobulin (IVIG), and hydroxychloroquine during pregnancy, resulting in partial resolution of numbness below the waist. However, due to irregular medication adherence outside the hospital setting, she developed weakness in her right lower limb accompanied by inability to move it, while her left lower limb still had some mobility but occasional numbness along with urinary and fecal incontinence. Ten days later, she was admitted to the emergency department where an emergency cesarean section was performed to deliver a healthy baby boy. However, her condition worsened postpartum as she developed high fever accompanied by bilateral lower limb paralysis and weakness along with loss of voluntary control over urination and defecation. The patient underwent ano-ther course of treatment consisting of steroids and IVIG; however there was limited improvement in symptoms observed after this intervention. Following administration of rituximab for the first time, the patient developed urinary tract infection which was successfully managed before continuing regular infusions. In later stages the patient could walk slightly with a limp and regained control over urination and defecation, allowing her to resume normal activities. This case suggests that combination therapy with steroids, IVIG, and hydroxychloroquine should be considered for the patients with pregnancy-associated NMOSD combined with Sjögren's syndrome. Rituximab can significantly improve symptoms such as postpartum paralysis in patients with NMOSD, however, there may be a risk of infection associated with its use.
Adult
;
Female
;
Humans
;
Pregnancy
;
Cesarean Section/adverse effects*
;
Critical Illness
;
Hydroxychloroquine/therapeutic use*
;
Hypesthesia/complications*
;
Immunoglobulins, Intravenous/therapeutic use*
;
Inflammation/complications*
;
Neuromyelitis Optica/diagnosis*
;
Paralysis/complications*
;
Pregnancy Complications/therapy*
;
Rituximab/therapeutic use*
;
Sjogren's Syndrome/complications*
;
Steroids/therapeutic use*
;
Vision Disorders
3.Expressions of interleukin-17 and interleukin-8 in the prostatic tissue of the patients with BPH or BPH with inflammation.
Rui GAO ; Qi-Xiang LIU ; Hui-Liang ZHOU ; Lin-Sheng CAO ; Tao JIANG ; Song-Xi TANG ; Yi-Lang DING
National Journal of Andrology 2017;23(8):697-702
Objective:
To investigate the expressions of interleukin-17 (IL-17) and interleukin-8 (IL-8) in benign prostatic hyperplasia (BPH) and BPH complicated with histological inflammation and their significance.
METHODS:
According to the results of HE staining, we divided 60 cases of BPH treated by transurethral resection of the prostate (TURP) into a BPH group (n = 23) and a BPH with inflammation group (n = 37). We analyzed the clinical data of the patients and determined the mRNA and protein expressions of IL-17 and IL-8 by immunohistochemistry, real-time fluorescence quantitative PCR, and Western blot, respectively.
RESULTS:
Compared with the BPH patients complicated with inflammation, the BPH group showed significantly lower International Prostate Symptom Score (IPSS) (29.1 ± 6.2 vs 21.6 ± 3.7), quality of life score (QoL) (5.4 ± 1.3 vs 4.4 ± 1.6), postvoid residual urine volume (RUV) ([198.6 ± 15.5] vs [98.2 ± 19.3] ml), prostate volume ([69.2 ± 24.1] vs [49.8 ± 16.5] ml), PSA level ([7.4 ± 1.9] vs [2.8 ± 0.8] μg/L) and serum c-reactive protein content (CRP) ([5.1±2.0] vs [1.5±0.6] mg/L), but a higher maximum urine flow rate (Qmax) ([4.7 ± 2.1] vs [8.2 ± 1.8] ml/s) (all P<0.05). The former group had a significantly higher incidence rate of urinary retention than the latter (32.4% [12/37] vs 8.69% [2/23]), mRNA expressions of IL-17 (0.303 ± 0.076 vs 0.042 ± 0.019) and IL-8 (0.536 ± 0.059 vs 0.108 ± 0.025), and protein expressions of IL-17 (0.88 ± 0.10 vs 0.34 ± 0.05) and IL-8 (1.07 ± 0.08 vs 0.43 ± 0.04) (all P<0.05).
CONCLUSIONS
The expressions of IL-17 and IL-8 are upregulated in the prostatic tissue of the BPH patients with inflammation, which may play a significant role in the development and progression of BPH.
Disease Progression
;
Humans
;
Inflammation
;
metabolism
;
Interleukin-17
;
metabolism
;
Interleukin-8
;
metabolism
;
Male
;
Organ Size
;
Prostate
;
pathology
;
Prostatic Hyperplasia
;
complications
;
metabolism
;
Quality of Life
;
RNA, Messenger
;
metabolism
;
Transurethral Resection of Prostate
;
Treatment Outcome
;
Urinary Retention
;
diagnosis
;
etiology
4.Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan.
Liang XU ; Ping LI ; Wei LU ; Qiyu SHI ; Ruifang SHI ; Xiaoying ZHANG ; Yonggang LIU ; Qiujing WANG ; Jangao FAN ; Yuqiang MI
Chinese Journal of Hepatology 2016;24(2):108-113
OBJECTIVETo investigate the value of controlled attenuation parameter (CAP) in the diagnosis of fatty liver using FibroScan in patients with chronic liver disease (CLD).
METHODSA prospective cohort study was performed for the patients with chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) who underwent liver pathological examination followed by CAP measurement within 1 week in The Second People's Hospital of Tianjin from February 2013 to May 2014. According to related guidelines, hepatocyte steatosis was classified as S0: <5%, S1: 5%-33%, S2: 34%-66%, or S3: ≥67%. The receiver operating characteristic (ROC) curves were plotted with positive results as the diagnostic criteria, and the optimal cut-off values were determined at the maximum Youden index. Single linear regression and multiple stepwise regression were applied to analyze the influencing factors for CAP.
RESULTSA total of 427 patients were enrolled, consisting of 19 patients (4.4%) with NAFLD, 383 (89.7%) with CHB, and 25 (5.9%) with CHC. The optimal cut-off values for CAP in the diagnosis of steatosis ≥5%, ≥34%, and ≥67% were 230 dB/m, 252 dB/m, and 283 dB/m, respectively, and the areas under the ROC curve were 0.803, 0.942, and 0.938, respectively (Z = 14.194, 28.385, and 16.486, respectively, all P < 0.01). CAP differentiated S0 from S1, S1 from S2, S0 from S2, S0 from S3, and S1 from S3 (Z = 10.109, 10.224, 47.81, 29.917, and 10.999, all P < 0.01), but was not able to differentiate S2 from S3 (Z = 0.656, P = 0.5116). The single linear regression and multiple stepwise regression analyses showed that only body mass index (BMI; B = 4.001, P < 0.01) and hepatic steatosis (B = 33.015, P = 0.000) were correlated with CAP. The coincidence rates between CAP and liver pathological diagnosis were 77.4%, 81.0%, and 96.2% for S0, S3, and ≥S2, respectively.
CONCLUSIONCAP has a good value in the diagnosis of fatty liver in CLD patients, and can well differentiate between all stages of fatty liver except S2 and S3. CAP is influenced by BMI, but is not found to be associated with liver fibrosis, inflammation, liver stiffness measurement, and etiology.
Area Under Curve ; Biopsy ; Body Mass Index ; Cell Differentiation ; Elasticity Imaging Techniques ; Hepatitis B, Chronic ; complications ; Hepatitis C, Chronic ; complications ; Humans ; Inflammation ; complications ; Linear Models ; Liver Cirrhosis ; complications ; Multivariate Analysis ; Non-alcoholic Fatty Liver Disease ; complications ; diagnosis ; Prospective Studies ; ROC Curve
5.Diagnosis and Treatment of Congenital H-type Rectovestibular Fistula.
Younjung KIM ; Minjung KIM ; Sanghoon LEE ; Jeong Meen SEO ; Suk Koo LEE
Journal of the Korean Association of Pediatric Surgeons 2016;22(2):19-22
PURPOSE: The congenital H-type rectovestibular fistula, a fistula between the anorectum and genital tract besides a normal anus is a rare variant of anorectal deformities. This disease needs proper treatment but there are no standard of diagnosis and treatment. The purpose of this report is to review a 13-year experience of approach and management for H-type rectovestibular fistula at a single institution. METHODS: From February 2002 to August 2015, we cared for 11 patients who had congenital H-type rectovestibular fistula and reviewed their clinical presentation, accompanied anomalies, diagnostic modalities, operative technique, and postoperative progress. RESULTS: Most patients with H-type rectovestibular fistula presented with symptoms including vestibular defecation and major labial abscess. We could find the fistula tract in most of patients by fistulography using contrast dye. All of the patients had been operated. There were 2 recurrences after surgical treatment who had inflammation and infection associated with the fistula. All other patients recovered without complications. CONCLUSION: We think the operation including fistulectomy and repair of perineal body through a transanal approach can be a feasible option to the congenital H-type rectovestibular fistula. Also, combined inflammation and infection should be treated prior to surgery to reduce postoperative complications.
Abscess
;
Anal Canal
;
Congenital Abnormalities
;
Defecation
;
Diagnosis*
;
Fistula*
;
Humans
;
Inflammation
;
Postoperative Complications
;
Recurrence
6.Imaging findings of mimickers of hepatocellular carcinoma.
Tae Kyoung KIM ; Eunchae LEE ; Hyun Jung JANG
Clinical and Molecular Hepatology 2015;21(4):326-343
Radiological imaging plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) as the noninvasive diagnosis of HCC in high-risk patients by typical imaging findings alone is widely adopted in major practice guidelines for HCC. While imaging techniques have markedly improved in detecting small liver lesions, they often detect incidental benign liver lesions and non-hepatocellular malignancy that can be misdiagnosed as HCC. The most common mimicker of HCC in cirrhotic liver is nontumorous arterioportal shunts that are seen as focal hypervascular liver lesions on dynamic contrast-enhanced cross-sectional imaging. Rapidly enhancing hemangiomas can be easily misdiagnosed as HCC especially on MR imaging with liver-specific contrast agent. Focal inflammatory liver lesions mimic HCC by demonstrating arterial-phase hypervascularity and subsequent washout on dynamic contrast-enhanced imaging. It is important to recognize the suggestive imaging findings for intrahepatic cholangiocarcinoma (CC) as the management of CC is largely different from that of HCC. There are other benign mimickers of HCC such as angiomyolipomas and focal nodular hyperplasia-like nodules. Recognition of their typical imaging findings can reduce false-positive HCC diagnosis.
Carcinoma, Hepatocellular/*diagnosis/radiography
;
Diagnosis, Differential
;
Hemangioma/complications/radiography/ultrasonography
;
Hepatitis B/complications
;
Humans
;
Inflammation/radiography/ultrasonography
;
Liver/radiography/ultrasonography
;
Liver Cirrhosis/complications/radiography
;
Liver Neoplasms/*diagnosis/radiography
;
Magnetic Resonance Imaging
;
Non-alcoholic Fatty Liver Disease/radiography/ultrasonography
7.Imaging of acute cholecystitis and cholecystitis-associated complications in the emergency setting.
Ashish CHAWLA ; Jerome Irai BOSCO ; Tze Chwan LIM ; Sivasubramanian SRINIVASAN ; Hui Seong TEH ; Jagadish Narayana SHENOY
Singapore medical journal 2015;56(8):438-quiz 444
Acute cholecystitis is a common cause of right upper quadrant pain in patients presenting at the emergency department. Early diagnosis and recognition of associated complications, though challenging, are essential for timely management. Imaging studies, including ultrasonography, computed tomography and magnetic resonance imaging, are increasingly utilised for the evaluation of suspected cases of cholecystitis. These investigations help in diagnosis, identification of complications and surgical planning. Imaging features of acute cholecystitis have been described in the literature and are variable, depending on the stage of inflammation. This article discusses the spectrum of cholecystitis-associated complications and their imaging manifestations. We also suggest a checklist for the prompt and accurate identification of complications in acute cholecystitis.
Abdominal Pain
;
diagnosis
;
Adult
;
Aged
;
Cholecystitis
;
complications
;
diagnostic imaging
;
Cholecystitis, Acute
;
complications
;
diagnostic imaging
;
Diagnosis, Differential
;
Emergency Medicine
;
methods
;
Emergency Service, Hospital
;
Female
;
Humans
;
Inflammation
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Tomography, X-Ray Computed
;
Ultrasonography
8.Magnetic resonance imaging of diabetic foot complications.
Keynes T A LOW ; Wilfred C G PEH
Singapore medical journal 2015;56(1):23-quiz 34
This pictorial review aims to illustrate the various manifestations of the diabetic foot on magnetic resonance (MR) imaging. The utility of MR imaging and its imaging features in the diagnosis of pedal osteomyelitis are illustrated. There is often difficulty encountered in distinguishing osteomyelitis from neuroarthropathy, both clinically and on imaging. By providing an accurate diagnosis based on imaging, the radiologist plays a significant role in the management of patients with complications of diabetic foot.
Aged
;
Aged, 80 and over
;
Cellulitis
;
diagnosis
;
Diabetic Foot
;
complications
;
diagnosis
;
Female
;
Gangrene
;
diagnosis
;
Humans
;
Inflammation
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Osteomyelitis
;
diagnosis
;
physiopathology
;
Risk Factors
;
Skin Diseases
;
diagnosis
;
Ulcer
;
diagnosis
9.Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Su Min LEE ; Andrew RUSSELL ; Giles HELLAWELL
Korean Journal of Urology 2015;56(11):749-755
PURPOSE: Inflammation-based prognostic scores including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) are associated with oncologic outcomes in diverse malignancies. We evaluated the predictive value of pretreatment prognostic scores in differentiating nonmuscle invasive (NMIBC) and muscle invasive bladder cancer (MIBC). MATERIALS AND METHODS: Consecutive transurethral resection of bladder tumour (TURBT) cases from January 2011 to December 2013 were analysed retrospectively. Patient demographics, tumour characteristics and prognostic scores results were recorded. Receiver operating characteristics curves were used to determine prognostic score cutoffs. Univariate and multivariate binomial logistic regression analysis was performed to evaluate the association between variables and MIBC. RESULTS: A total of 226 patients were included, with 175 and 51 having NMIBC (stages Ta and T1) and MIBC (stage T2+) groups, respectively. Median age was 75 years and 174 patients were male. The NLR cutoff was 3.89 and had the greatest area under the curve (AUC) of 0.710, followed by LMR (cutoff<1.7; AUC, 0.650) and PLR (cutoff>218; AUC, 0.642). Full blood count samples were taken a median of 12 days prior to TURBT surgery. Multivariate logistic regression analysis identified tumour grade G3 (odds ration [OR], 32.848; 95% confidence interval [CI], 9.818-109.902; p=0.000), tumour size> or =3 cm (OR, 3.353; 95% CI, 1.347-8.345; p=0.009) and NLR> or =3.89 (OR, 8.244; 95% CI, 2.488-27.316; p=0.001) as independent predictors of MIBC. CONCLUSIONS: NLR may provide a simple, cost-effective and easily measured marker for MIBC. It can be performed at the time of diagnostic flexible cystoscopy, thereby assisting in the planning of further treatment.
Aged
;
Aged, 80 and over
;
Blood Platelets/pathology
;
Carcinoma, Transitional Cell/complications/pathology/*surgery
;
Female
;
Humans
;
Inflammation/diagnosis/*etiology
;
Leukocyte Count
;
Lymphocyte Count
;
Male
;
Muscle, Smooth/pathology
;
Neoplasm Grading
;
Neoplasm Invasiveness
;
Neoplasm Staging
;
Neutrophils/pathology
;
Platelet Count
;
Predictive Value of Tests
;
Prognosis
;
Retrospective Studies
;
Urinary Bladder Neoplasms/complications/pathology/*surgery
10.Portal Vein Thrombosis with Sepsis Caused by Inflammation at Colonic Stent Insertion Site.
Su Jin CHOI ; Ji Won MIN ; Jong Min YUN ; Hye Shin AHN ; Deok Jae HAN ; Hyeon Jeong LEE ; Young Ok KIM
The Korean Journal of Gastroenterology 2015;65(5):316-320
Portal vein thrombosis is an uncommon but an important cause of portal hypertension. The most common etiological factors of portal vein thrombosis are liver cirrhosis and malignancy. Albeit rare, portal vein thrombosis can also occur in the presence of local infection and inflammation such as pancreatitis or cholecystitis. A 52-year-old male was admitted because of general weakness and poor oral intake. He had an operation for colon cancer 18 months ago. However, colonic stent had to be inserted afterwards because stricture developed at anastomosis site. Computed tomography taken at admission revealed portal vein thrombosis and inflammation at colonic stent insertion site. Blood culture was positive for Escherichia coli. After antibiotic therapy, portal vein thrombosis resolved. Herein, we report a case of portal vein thrombosis with sepsis caused by inflammation at colonic stent insertion site which was successfully treated with antibiotics.
Anti-Bacterial Agents/therapeutic use
;
Cholecystitis/etiology
;
Colonic Neoplasms/pathology/therapy
;
Escherichia coli/isolation & purification
;
Escherichia coli Infections/drug therapy/etiology
;
Humans
;
Inflammation/*etiology
;
Liver/diagnostic imaging
;
Male
;
Middle Aged
;
Pancreatitis/etiology
;
Portal Vein
;
Sepsis/*diagnosis/drug therapy/microbiology
;
Sigmoidoscopy
;
Stents/*adverse effects
;
Tomography, X-Ray Computed
;
Venous Thrombosis/complications/*diagnosis

Result Analysis
Print
Save
E-mail